Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-428-9 | CAS number: 12225-21-7 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 19140:1.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- chronic toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- publication
- Title:
- Skin Painting Studies In Mice with 14 Fd & C & D & C Colors: FD & C Blue No.1 , Red No.3, And Yellow No.5, D & C Red No.7, Red No.9, Red No.10, Red No.19, Red No.21 , Red No.27, Red No.31, Red No.36, Orange No.5, Orange No.10, And Orange No.17
- Author:
- Steven Carson
- Year:
- 1 984
- Bibliographic source:
- J. Toxicol. Cut. & Ocular Toxicol. 3(4), 357-370 (1984)
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Refer below principle
- Principles of method if other than guideline:
- Combined repeated dose and carcinogenicity study by the dermal route was performed to determine the dermal toxic nature of the test compound 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate [FD & C Yellow No. 5 (tartrazine)] upon repeated application.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate
- EC Number:
- 217-699-5
- EC Name:
- Trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate
- Cas Number:
- 1934-21-0
- Molecular formula:
- C16-H12-N4-O9-S2.3Na
- IUPAC Name:
- trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate
- Details on test material:
- - Name of test material (as cited in study report):trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate
- Molecular formula :C16H12N4O9S2.3Na
- Substance type:organic
- Physical state:Soild
- Impurities (identity and concentrations):8%
Constituent 1
- Specific details on test material used for the study:
- - Name of test material :trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate
- Molecular formula : C16H12N4O9S2.3Na
- Substance type: organic
- Physical state: Soild
- Impurities (identity and concentrations): 8%
Test animals
- Species:
- mouse
- Strain:
- Swiss Webster
- Details on species / strain selection:
- No data
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: No data
- Age at study initiation: No data
- Weight at study initiation: No data
- Fasting period before study: No data available
- Housing: Each animal was assigned an identification number and individually housed in a supported wire cage.
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data available
- Humidity (%):No data available
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): No data available
IN-LIFE DATES: From: To: No data available
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- other: distilled water
- Details on exposure:
- TEST SITE
- Area of exposure: 6 cm²
- % coverage: No data available
- Type of wrap if used: No data available
- Time intervals for shavings or clipplings: Subsequent periodic clipping was performed according to the rate of hair growth
REMOVAL OF TEST SUBSTANCE
- Washing (if done): No data available
- Time after start of exposure: No data available
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 ml of the vehicle containing 133.4 mg test material
- Concentration (if solution): 0 or 133.4 mg
- Constant volume or concentration used: yes
- For solids, paste formed: no data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): Distilled water
- Amount(s) applied (volume or weight with unit): 0.1 mL
- Concentration (if solution): 0.1 mL
- Lot/batch no. (if required): Not data
- Purity: no data available
USE OF RESTRAINERS FOR PREVENTING INGESTION: no data - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- 475 days
- Frequency of treatment:
- Twice weekly
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0 or 133.4 mg
Basis:
other: Mean dose of dye applied
- No. of animals per sex per dose:
- Vehicle Control: 150 females and 150 males = 300 mice
Positive Control: 50 females and 50 males = 100 mice
Test Dye Materials: 50 females and 50 males = 100 mice - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Preliminary to establishing the dosages for the skin painting studies, the amounts of lipstick ingested by women was established in a study utilizing female volunteers
- Rationale for animal assignment (if not random): Animals were assigned an identification number
- Rationale for selecting satellite groups: No data available
- Post-exposure recovery period in satellite groups: No data available
- Section schedule rationale (if not random): No data available - Positive control:
- 3,4-benzpyrene
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
- Cage side observations checked in table [No.?] were included.
DETAILED CLINICAL OBSERVATIONS: no data
- Time schedule: no data
BODY WEIGHT: no data
- Time schedule for examinations: no data
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): no data
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data
FOOD EFFICIENCY: No data
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
- Time schedule for examinations: No data
OPHTHALMOSCOPIC EXAMINATION: No data - Time schedule for examinations:
- Dose groups that were examined: No data
HAEMATOLOGY: No data
- Time schedule for collection of blood: No data
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: No data
- Parameters checked in table [No.?] were examined.
DERMAL IRRITATION (if dermal study): No data
- Time schedule for examinations: No data
CLINICAL CHEMISTRY: No data
- Time schedule for collection of blood: No data
- Animals fasted: No data
- How many animals: No data
- Parameters checked in table [No.?] were examined.
URINALYSIS: No data
- Time schedule for collection of urine: No data
- Metabolism cages used for collection of urine: No data
- Animals fasted: No data
- Parameters checked in table [No.?] were examined.
NEUROBEHAVIOURAL EXAMINATION: No data
- Time schedule for examinations:
- Dose groups that were examined:
- Battery of functions tested: No data sensory activity / grip strength / motor activity / other: No data
OTHER: - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, Animals that died, those sacrificed moribund, and those surviving the 18-month experimental period were necropsied.The following tissues were selected for examination:the brain, pituitary, thyroid, thymus, liver, spleen, kidney, adrenal, stomach,small intestines, large intestines, urinary bladder, axillary lymph nodes, testes, ovary,skin from area of treatment, any tissue masses, grossly abnormal organs, or tissues.
HISTOPATHOLOGY: Yes, after termination of the study, tissues were selected for histopathology.The following tissues were selected for examination: skin and any grossly abnormal organs and tissues of all animals in the color experimental groups; skin and any grossly abnormal organs and tissues of approximately 50 vehicle control animals (approximately equal number of males and females); complete pathology on five males and five females randomly selected vehicle control animals that survived the 18-month experimental period; and complete pathology on five males and five females randomly selected vehicle control animals that survived the 18-month experimental period; and complete pathology of five male and five female animals from the positive control group that included induced skin lesions.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Dermal irritation:
- not specified
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The incidence and severity of lesions of interstitial nephritis, cystitis, amyloidosis, and bronchopneumonia varied slightly between the treated test group and the control. However, there were no significant variations that could be attributed to application of the test compound
- Histopathological findings: neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The number of neoplasias involving the mammary glands or internal organs varied somewhat between the test group and the control, but there was, however, no apparent change in their pattern which could be attributed to the dermal application of the test dye compound
- Details on results:
- CLINICAL SIGNS AND MORTALITY
Survival was approximately equivalent in all experimental groups except the positive controls who died earlier consistent with survival recorded by others for 3,4-benzpyrene treated mice.
HISTOPATHOLOGY
Extramedullary hematopoesis was found in all treated groups, equivalent to the findings in the controls.
HISTOPATHOLOGY: NEOPLASTIC
The repeated application of 0.1 ml containing 1 mg dye for 18 months did not increase the incidence of neoplasia when compared to controls in any of the groups receiving application of the test substance.
Other: The incidence of ectoparasitism was greater in the dye treated group than found in the vehicle controls. This increase in skin mite infestation may have contributed to the increase in epidermal change dermatitis, acanthosis, and hyperkeratosis observed in the dye treated group
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 0.01 other: mg dye
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: The repeated application of 0.1 ml containing 1 mg dye did not increase the incidence of neoplasia when compared to controls.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The no observed adverse effect level (NOAEL) for the repeated dose toxicity study of trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate [FD & C Yellow No. 5 (tartrazine)] was considered to be 133.4 mg of dye when administered dermally to mice in a chronic study of 18 months.
- Executive summary:
Chronic toxicity study was conducted to evaluate the toxic effects of repeated administration of trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophe nylazo)pyrazole-3-carboxylate [FD & C Yellow No. 5 (tartrazine)] to ICR Swiss Webster mouse by the dermal route. A groups of 100 mice (50 per sex) plus an additional positive control group of the same size and a vehicle control group of 300 mice (150 per sex) were used in the study.All colors were prepared at 1.0% suspensions in water. The positive control received 3,4-benzpyrene dissolved in acetone. The test chemical was applied to the clipped dorsal area mice. The animals were observed for mortality, clinical signs and gross pathology and histopathology was performed. Survival was approximately equivalent in all experimental groups except the positive controls who died earlier consistent with survival recorded by others for 3,4-benzpyrene treated mice. Extramedullary hematopoesis was found in all treated groups, equivalent to the findings in the controls. The repeated application of 0.1 ml containing 1 mg dye to the dorsal area of ICR(Swiss Webster derived) white mice twice weekly for 18 months did not produce any adverse effects and did not increase the incidence of neoplasia when compared to controls in any of the groups receiving application of the test substance.Thus the no observed adverse effect level (NOAEL) of the study was considered to be 133.4 mg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.